newsfilter
← Latest News
GlobeNewswire·

Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment Conference

DURHAM, N.C., Sept. 09, 2021 (GLOBE NEWSWIRE) -- Heat Biologics, Inc. (NASDAQ:HTBX), a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, today announced that Jeff Wolf, Chief Executiv